Neopath (NPTH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neopath (NPTH)

NPTH 0.000600

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sigmund who wrote (143)	5/8/1998 8:28:00 PM
From: Jim Armstrong	Read Replies (1) of 178

To be a little more specific, I worked with a couple of the folks (in another technology-based business) before they joined Neopath a few years back. I know them and their work style and quality very well. I also interviewed at NPTH at one point and got acquainted with several others in their technical leadership. (I took another position based on timing, not disinterest on my part). Re: "It is his fiduciary duty to represent the interests of the shareholders not the diseased and potentially diseased. If he can't represent the shareholders, he should retire." I don't quite agree with this. He certainly has responsibilities to the shareholders. But with this particular business, if the interests of the "diseased and potentially diseased" are not served by NPTH's technology, then NPTH has no viable business. That's the problem they set out to solve. That's what they are about (instead of oceanic mining, magnetometric archeology, or satellite image analysis or whatever). No patient benefit, . . . no business, and that certainly that does not serve the shareholders' interests. JimA

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next